ALTEOGEN Revenue

In the year 2024, ALTEOGEN had annual revenue of 102.85B KRW with 6.56% growth. ALTEOGEN had revenue of 50.83B in the quarter ending December 31, 2024, with 127.42% growth.

Revenue

102.85B

Revenue Growth

+6.56%

P/S Ratio

203.64

Revenue / Employee

709.34M

Employees

145

Market Cap

20.94T

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	102.85B	6.33B	6.56%
Dec 31, 2023	96.52B	67.72B	235.08%
Dec 31, 2022	28.81B	-9.94B	-25.65%
Dec 31, 2021	38.75B	-3.68B	-8.67%
Dec 31, 2020	42.43B	13.20B	45.15%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	68.13B
LigaChem Biosciences	125.90B
PharmaResearch	350.12B
Sam Chun Dang Pharm.	210.92B

Revenue Rankings